MENU
ENOV
Stock ticker: NYSE
PRICE
CHANGE
CAPITALIZATION

ENOV stock forecast, quote, news & analysis

Enovis Corp is a medical technology manufacturer and distributor of medical devices used in reconstructive surgery, rehabilitation, pain management, and physical therapy... Show more

ENOV
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
Interact to see
Advertisement
A.I.Advisor
a Summary for ENOV with price predictions
Jul 02, 2026

ENOV in -8.99% downward trend, declining for three consecutive days on July 01, 2026

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where ENOV declined for three days, in of 345 cases, the price declined further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 57 cases where ENOV's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

ENOV moved below its 50-day moving average on May 27, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for ENOV crossed bearishly below the 50-day moving average on June 02, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

The Aroon Indicator for ENOV entered a downward trend on July 02, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on July 02, 2026. You may want to consider a long position or call options on ENOV as a result. In of 81 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for ENOV just turned positive on July 02, 2026. Looking at past instances where ENOV's MACD turned positive, the stock continued to rise in of 43 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ENOV advanced for three days, in of 269 cases, the price rose further within the following month. The odds of a continued upward trend are .

ENOV may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. ENOV’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.830) is normal, around the industry mean (10.755). P/E Ratio (0.000) is within average values for comparable stocks, (61.580). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.711). ENOV has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.018). P/S Ratio (0.535) is also within normal values, averaging (23.791).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ENOV’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Abbott Laboratories (NYSE:ABT), Medtronic plc (NYSE:MDT), Boston Scientific Corp (NYSE:BSX), Edwards Lifesciences Corp (NYSE:EW).

Industry description

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

Market Cap

The average market capitalization across the Medical/Nursing Services Industry is 5.67B. The market cap for tickers in the group ranges from 1.86K to 166.17B. ABT holds the highest valuation in this group at 166.17B. The lowest valued company is CSAY at 1.86K.

High and low price notable news

The average weekly price growth across all stocks in the Medical/Nursing Services Industry was 3%. For the same Industry, the average monthly price growth was -0%, and the average quarterly price growth was -11%. IVF experienced the highest price growth at 98%, while VTAK experienced the biggest fall at -35%.

Volume

The average weekly volume growth across all stocks in the Medical/Nursing Services Industry was 110%. For the same stocks of the Industry, the average monthly volume growth was -52% and the average quarterly volume growth was 422%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 51
P/E Growth Rating: 76
Price Growth Rating: 60
SMR Rating: 90
Profit Risk Rating: 94
Seasonality Score: 0 (-100 ... +100)
View a ticker or compare two or three
ENOV
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

a manufacturer of fluid handling and industrial positioning products

Industry MedicalNursingServices

Profile
Details
Industry
Industrial Machinery
Address
2711 Centerville Road
Phone
+1 302 252-9160
Employees
6550
Web
https://www.enovis.com
ENOV in -8.99% downward trend, declining for three consecutive days on July 01, 2026